Back
ESC Premium Access

Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial.

Session: Meet the Trialists - EMANATE
Topic: Atrial fibrillation (AF)
Speaker: Professor M. Ezekowitz (Philadelphia, US)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Professor Michael Ezekowitz

Thomas Jefferson University Hospital, Philadelphia (United States of America)
4 presentations
0 follower

Access the full session

Meet the Trialists - EMANATE

Speakers: Professor M. Ezekowitz
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources